Literature DB >> 24944027

The multifaceted mineralocorticoid receptor.

Elise Gomez-Sanchez1, Celso E Gomez-Sanchez.   

Abstract

The primary adrenal cortical steroid hormones, aldosterone, and the glucocorticoids cortisol and corticosterone, act through the structurally similar mineralocorticoid (MR) and glucocorticoid receptors (GRs). Aldosterone is crucial for fluid, electrolyte, and hemodynamic homeostasis and tissue repair; the significantly more abundant glucocorticoids are indispensable for energy homeostasis, appropriate responses to stress, and limiting inflammation. Steroid receptors initiate gene transcription for proteins that effect their actions as well as rapid non-genomic effects through classical cell signaling pathways. GR and MR are expressed in many tissues types, often in the same cells, where they interact at molecular and functional levels, at times in synergy, others in opposition. Thus the appropriate balance of MR and GR activation is crucial for homeostasis. MR has the same binding affinity for aldosterone, cortisol, and corticosterone. Glucocorticoids activate MR in most tissues at basal levels and GR at stress levels. Inactivation of cortisol and corticosterone by 11β-HSD2 allows aldosterone to activate MR within aldosterone target cells and limits activation of the GR. Under most conditions, 11β-HSD1 acts as a reductase and activates cortisol/corticosterone, amplifying circulating levels. 11β-HSD1 and MR antagonists mitigate inappropriate activation of MR under conditions of oxidative stress that contributes to the pathophysiology of the cardiometabolic syndrome; however, MR antagonists decrease normal MR/GR functional interactions, a particular concern for neurons mediating cognition, memory, and affect.
© 2014 American Physiological Society

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24944027      PMCID: PMC4521600          DOI: 10.1002/cphy.c130044

Source DB:  PubMed          Journal:  Compr Physiol        ISSN: 2040-4603            Impact factor:   9.090


  506 in total

Review 1.  Editorial: Cardiac steroidogenesis--new sites of synthesis, or much ado about nothing?

Authors:  C E Gomez-Sanchez; E P Gomez-Sanchez
Journal:  J Clin Endocrinol Metab       Date:  2001-11       Impact factor: 5.958

2.  Functional characterization of Src-interacting Na/K-ATPase using RNA interference assay.

Authors:  Man Liang; Ting Cai; Jiang Tian; Weikai Qu; Zi-Jian Xie
Journal:  J Biol Chem       Date:  2006-05-12       Impact factor: 5.157

3.  Aldosterone-sensitive neurons in the rat central nervous system.

Authors:  Joel C Geerling; Mitsuhiro Kawata; Arthur D Loewy
Journal:  J Comp Neurol       Date:  2006-01-20       Impact factor: 3.215

4.  Mineralocorticoid receptor activation and oxidative stress.

Authors:  John W Funder
Journal:  Hypertension       Date:  2007-10-08       Impact factor: 10.190

Review 5.  Mechanisms of mineralocorticoid action.

Authors:  Peter J Fuller; Morag J Young
Journal:  Hypertension       Date:  2005-11-14       Impact factor: 10.190

6.  Regulation of mineralocorticoid receptor expression during neuronal differentiation of murine embryonic stem cells.

Authors:  Mathilde Munier; Geri Meduri; Say Viengchareun; Philippe Leclerc; Damien Le Menuet; Marc Lombès
Journal:  Endocrinology       Date:  2010-03-05       Impact factor: 4.736

Review 7.  (Re-)activation of neurons in aging and dementia: lessons from the hypothalamus.

Authors:  Dick F Swaab; Ai-Min Bao
Journal:  Exp Gerontol       Date:  2010-09-15       Impact factor: 4.032

8.  Expression of aldosterone synthase gene in failing human heart: quantitative analysis using modified real-time polymerase chain reaction.

Authors:  Michihiro Yoshimura; Shota Nakamura; Teruhiko Ito; Masafumi Nakayama; Eisaku Harada; Yuji Mizuno; Tomohiro Sakamoto; Megumi Yamamuro; Yoshihiko Saito; Kazuwa Nakao; Hirofumi Yasue; Hisao Ogawa
Journal:  J Clin Endocrinol Metab       Date:  2002-08       Impact factor: 5.958

Review 9.  Inactivating mutations of the mineralocorticoid receptor in Type I pseudohypoaldosteronism.

Authors:  P Sartorato; Y Khaldi; A-L Lapeyraque; D Armanini; U Kuhnle; R Salomon; M Caprio; S Viengchareun; M Lombès; M-C Zennaro
Journal:  Mol Cell Endocrinol       Date:  2004-03-31       Impact factor: 4.102

10.  Depot-specific steroidogenic gene transcription in human adipose tissue.

Authors:  Scott M MacKenzie; Shahzya S Huda; Naveed Sattar; Robert Fraser; John M C Connell; Eleanor Davies
Journal:  Clin Endocrinol (Oxf)       Date:  2008-04-10       Impact factor: 3.478

View more
  75 in total

Review 1.  Aldosterone Production and Signaling Dysregulation in Obesity.

Authors:  Andrea Vecchiola; Carlos F Lagos; Cristian A Carvajal; Rene Baudrand; Carlos E Fardella
Journal:  Curr Hypertens Rep       Date:  2016-03       Impact factor: 5.369

Review 2.  The expanding class of mineralocorticoid receptor modulators: New ligands for kidney, cardiac, vascular, systemic and behavioral selective actions.

Authors:  E Bădilă
Journal:  Acta Endocrinol (Buchar)       Date:  2020 Oct-Dec       Impact factor: 0.877

Review 3.  Human steroid biosynthesis, metabolism and excretion are differentially reflected by serum and urine steroid metabolomes: A comprehensive review.

Authors:  Lina Schiffer; Lise Barnard; Elizabeth S Baranowski; Lorna C Gilligan; Angela E Taylor; Wiebke Arlt; Cedric H L Shackleton; Karl-Heinz Storbeck
Journal:  J Steroid Biochem Mol Biol       Date:  2019-07-27       Impact factor: 4.292

Review 4.  Nuclear Receptor Function through Genomics: Lessons from the Glucocorticoid Receptor.

Authors:  Daniel M Cohen; David J Steger
Journal:  Trends Endocrinol Metab       Date:  2017-05-08       Impact factor: 12.015

Review 5.  Mineralocorticoid Receptors, Neuroinflammation and Hypertensive Encephalopathy.

Authors:  Maria Elvira Brocca; Luciana Pietranera; Edo Ronald de Kloet; Alejandro Federico De Nicola
Journal:  Cell Mol Neurobiol       Date:  2018-08-16       Impact factor: 5.046

Review 6.  Aldosterone and the Mineralocorticoid Receptor: Risk Factors for Cardiometabolic Disorders.

Authors:  Rajesh Garg; Gail K Adler
Journal:  Curr Hypertens Rep       Date:  2015-07       Impact factor: 5.369

7.  Eplerenone Reduces Atrial Fibrillation Burden Without Preventing Atrial Electrical Remodeling.

Authors:  Yoshio Takemoto; Rafael J Ramirez; Kuljeet Kaur; Oscar Salvador-Montañés; Daniela Ponce-Balbuena; Roberto Ramos-Mondragón; Steven R Ennis; Guadalupe Guerrero-Serna; Omer Berenfeld; José Jalife
Journal:  J Am Coll Cardiol       Date:  2017-12-12       Impact factor: 24.094

Review 8.  Immunohistochemistry of the Human Adrenal CYP11B2 in Normal Individuals and in Patients with Primary Aldosteronism.

Authors:  Celso E Gomez-Sanchez; Elise P Gomez-Sanchez; Koshiro Nishimoto
Journal:  Horm Metab Res       Date:  2020-04-14       Impact factor: 2.936

Review 9.  Emerging Targets of Diuretic Therapy.

Authors:  C-J Cheng; A R Rodan; C-L Huang
Journal:  Clin Pharmacol Ther       Date:  2017-07-10       Impact factor: 6.875

10.  Gene expression effects of glucocorticoid and mineralocorticoid receptor agonists and antagonists on normal human skeletal muscle.

Authors:  Jessica A Chadwick; J Spencer Hauck; Celso E Gomez-Sanchez; Elise P Gomez-Sanchez; Jill A Rafael-Fortney
Journal:  Physiol Genomics       Date:  2017-04-21       Impact factor: 3.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.